Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled Phase 2 trial of MLE4901 in women with polycystic ovary syndrome
2016-002179-91Phase 2Terminated
- Sponsor
- Millendo Therapeutics
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing MLE4901 with Placebo (2 arms). Primary endpoint: Change in duration of menstrual cycles. Started Sep 2016; status: terminated.
02
Drugs
pavinetant
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2016-002179-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002179-91.